메뉴 건너뛰기




Volumn 26, Issue 10, 2005, Pages 2488-2491

Multiple sclerosis and Alzheimer disease through the looking glass of MR imaging

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DONEPEZIL; GALANTAMINE; GLATIRAMER; MEMANTINE; MITOXANTRONE; NATALIZUMAB; PLACEBO; RIVASTIGMINE; CENTRAL NERVOUS SYSTEM AGENTS;

EID: 33644843158     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (9)

References (57)
  • 1
    • 0028318834 scopus 로고
    • The relative contributions of MRI, SPECT, and PET imaging in epilepsy
    • Spencer SS. The relative contributions of MRI, SPECT, and PET imaging in epilepsy. Epilepsia 1994;35:S72-S89
    • (1994) Epilepsia , vol.35
    • Spencer, S.S.1
  • 2
    • 0036136945 scopus 로고    scopus 로고
    • Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke
    • Parsons MW, Barber PA, Chalk J, et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002;51:28-37
    • (2002) Ann Neurol , vol.51 , pp. 28-37
    • Parsons, M.W.1    Barber, P.A.2    Chalk, J.3
  • 3
    • 1842506972 scopus 로고    scopus 로고
    • Advances in magnetic resonance imaging of brain tumours
    • Rees J. Advances in magnetic resonance imaging of brain tumours. Curr Opin Neurol 2003;16:643-650
    • (2003) Curr Opin Neurol , vol.16 , pp. 643-650
    • Rees, J.1
  • 4
    • 0026597219 scopus 로고
    • MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease
    • Jack CR Jr, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188
    • (1992) Neurology , vol.42 , pp. 183-188
    • Jack Jr., C.R.1    Petersen, R.C.2    O'Brien, P.C.3    Tangalos, E.G.4
  • 5
    • 0026469523 scopus 로고
    • Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography
    • Jobst KA, Smith AD, Szatmari M, et al. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 1992;340:1179-1183
    • (1992) Lancet , vol.340 , pp. 1179-1183
    • Jobst, K.A.1    Smith, A.D.2    Szatmari, M.3
  • 6
    • 0037007066 scopus 로고    scopus 로고
    • Imaging the progression of Alzheimer pathology through the brain
    • Smith AD. Imaging the progression of Alzheimer pathology through the brain. Proc Natl Acad Sci USA 2002;99:4135-4137
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 4135-4137
    • Smith, A.D.1
  • 7
    • 0042512332 scopus 로고    scopus 로고
    • Computer-assisted imaging to assess brain structure in healthy and diseased brains
    • Ashburner J, Csernansky JG, Davatzikos C, et al. Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol 2003;2:79-88
    • (2003) Lancet Neurol , vol.2 , pp. 79-88
    • Ashburner, J.1    Csernansky, J.G.2    Davatzikos, C.3
  • 8
    • 0036904784 scopus 로고    scopus 로고
    • Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry
    • Frisoni GB, Testa C, Zorzan A, et al. Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J Neurol Neurosurg Psychiatry 2002;73:657-664
    • (2002) J Neurol Neurosurg Psychiatry , vol.73 , pp. 657-664
    • Frisoni, G.B.1    Testa, C.2    Zorzan, A.3
  • 10
    • 0345276565 scopus 로고    scopus 로고
    • Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses
    • Mandelkow EM, Stamer K, Vogel R, et al. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging 2003;24:1079-1085
    • (2003) Neurobiol Aging , vol.24 , pp. 1079-1085
    • Mandelkow, E.M.1    Stamer, K.2    Vogel, R.3
  • 11
    • 0032724612 scopus 로고    scopus 로고
    • Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability
    • van Waesberghe JH, Kamphorst W, De Groot CJ, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747-754
    • (1999) Ann Neurol , vol.46 , pp. 747-754
    • Van Waesberghe, J.H.1    Kamphorst, W.2    De Groot, C.J.3
  • 12
    • 0034842126 scopus 로고    scopus 로고
    • Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions
    • Peterson JW, Bo L, Mork S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389-400
    • (2001) Ann Neurol , vol.50 , pp. 389-400
    • Peterson, J.W.1    Bo, L.2    Mork, S.3
  • 13
    • 0032796747 scopus 로고    scopus 로고
    • Axonal pathology in multiple sclerosis: Relationship to neurologic disability
    • Trapp BD, Ransohoff R, Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 1999;12:295-302
    • (1999) Curr Opin Neurol , vol.12 , pp. 295-302
    • Trapp, B.D.1    Ransohoff, R.2    Rudick, R.3
  • 14
    • 6944246720 scopus 로고    scopus 로고
    • Reduced brain tissue loss during randomised study of interferon β-1a in patients at presentation with syndromes suggestive of multiple sclerosis
    • Filippi M, Rovaris M. Inglese M, et al. Reduced brain tissue loss during randomised study of interferon β-1a in patients at presentation with syndromes suggestive of multiple sclerosis. Lancet 2004;364:1489-1496
    • (2004) Lancet , vol.364 , pp. 1489-1496
    • Filippi, M.1    Rovaris, M.2    Inglese, M.3
  • 15
    • 0037312536 scopus 로고    scopus 로고
    • Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis
    • Filippi M, Bozzalli M, Rovaris M, et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 2003;126:433-437
    • (2003) Brain , vol.126 , pp. 433-437
    • Filippi, M.1    Bozzalli, M.2    Rovaris, M.3
  • 16
    • 1842608971 scopus 로고    scopus 로고
    • Indirect evidence for early widespread gray matter involvement in relapsing remitting multiple sclerosis
    • Inglese M, Ge Y, Filippi M, et al. Indirect evidence for early widespread gray matter involvement in relapsing remitting multiple sclerosis. NeuroImage 2004;21:1825-1829
    • (2004) NeuroImage , vol.21 , pp. 1825-1829
    • Inglese, M.1    Ge, Y.2    Filippi, M.3
  • 17
    • 0032882173 scopus 로고    scopus 로고
    • Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
    • Coles AJ, Wing MG, Molyneux P, et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol 1999;46:296-304
    • (1999) Ann Neurol , vol.46 , pp. 296-304
    • Coles, A.J.1    Wing, M.G.2    Molyneux, P.3
  • 18
    • 0024436506 scopus 로고
    • Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
    • Itagaki S, McGeer PL, Akiyama H, et al. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 1989;24:173-182
    • (1989) J Neuroimmunol , vol.24 , pp. 173-182
    • Itagaki, S.1    McGeer, P.L.2    Akiyama, H.3
  • 19
    • 0035845283 scopus 로고    scopus 로고
    • In-vivo measurement of activated microglia in dementia
    • Cagnin A, Brooks DJ, Kennedy AM, et al. In-vivo measurement of activated microglia in dementia. Lancet 2001;358:461-467
    • (2001) Lancet , vol.358 , pp. 461-467
    • Cagnin, A.1    Brooks, D.J.2    Kennedy, A.M.3
  • 20
    • 0036732407 scopus 로고    scopus 로고
    • Inflammation takes on Alzheimer disease
    • Golde TE. Inflammation takes on Alzheimer disease. Nat Med 2002;8:936-938
    • (2002) Nat Med , vol.8 , pp. 936-938
    • Golde, T.E.1
  • 21
    • 0141453824 scopus 로고    scopus 로고
    • The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease
    • Aisen PS. The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. Lancet Neurol 2002;1:279-284
    • (2002) Lancet Neurol , vol.1 , pp. 279-284
    • Aisen, P.S.1
  • 23
    • 0034827157 scopus 로고    scopus 로고
    • Correlations between measures of multiple sclerosis pathology derived from T2, T1, magnetization transfer and diffusion tensor MR imaging
    • Iannucci G, Rovaris M, Giacomotti L, et al. Correlations between measures of multiple sclerosis pathology derived from T2, T1, magnetization transfer and diffusion tensor MR imaging. AJNR Am J Neuroradiol 2001;22:1462-1467
    • (2001) AJNR Am J Neuroradiol , vol.22 , pp. 1462-1467
    • Iannucci, G.1    Rovaris, M.2    Giacomotti, L.3
  • 24
    • 0034108287 scopus 로고    scopus 로고
    • Changes in the normal-appearing brain tissue and cognitive impairment in multiple sclerosis
    • Filippi M, Tortorella C, Rovaris M, et al. Changes in the normal-appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:157-161
    • (2000) J Neurol Neurosurg Psychiatry , vol.68 , pp. 157-161
    • Filippi, M.1    Tortorella, C.2    Rovaris, M.3
  • 25
    • 0034104079 scopus 로고    scopus 로고
    • Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis
    • Evangelou N, Esiri MM, Smith S, et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000;47:391-395
    • (2000) Ann Neurol , vol.47 , pp. 391-395
    • Evangelou, N.1    Esiri, M.M.2    Smith, S.3
  • 26
    • 0032767130 scopus 로고    scopus 로고
    • Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis
    • Rovaris M, Filippi M. Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis. Curr Opin Neurol 1999;12:337-344
    • (1999) Curr Opin Neurol , vol.12 , pp. 337-344
    • Rovaris, M.1    Filippi, M.2
  • 27
    • 0036266137 scopus 로고    scopus 로고
    • White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging
    • Bozzali M, Falini A, Franceschi M, et al. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2002;72:742-746
    • (2002) J Neurol Neurosurg Psychiatry , vol.72 , pp. 742-746
    • Bozzali, M.1    Falini, A.2    Franceschi, M.3
  • 28
    • 0037066123 scopus 로고    scopus 로고
    • Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia
    • Jack CR, Dickson DW, Parisi JE, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002;58:750-757
    • (2002) Neurology , vol.58 , pp. 750-757
    • Jack, C.R.1    Dickson, D.W.2    Parisi, J.E.3
  • 29
    • 0033962630 scopus 로고    scopus 로고
    • Diagnosis of Alzheimer's disease: MRI of the hippocampus vs delayed recall
    • Laakso MP, Hallikainen M, Hanninen T, et al. Diagnosis of Alzheimer's disease: MRI of the hippocampus vs delayed recall. Neuropsychologia 2000;38:579-584
    • (2000) Neuropsychologia , vol.38 , pp. 579-584
    • Laakso, M.P.1    Hallikainen, M.2    Hanninen, T.3
  • 30
    • 0028290204 scopus 로고
    • Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging
    • Meyerhoff DJ, MacKay S, Constans JM, et al. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1994;36:40-47
    • (1994) Ann Neurol , vol.36 , pp. 40-47
    • Meyerhoff, D.J.1    MacKay, S.2    Constans, J.M.3
  • 31
    • 0033846931 scopus 로고    scopus 로고
    • Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia
    • Hanyu H, Asano T, Iwamoto T, et al. Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia. AJNR Am J Neuroradiol 2000;21:1235-1242
    • (2000) AJNR Am J Neuroradiol , vol.21 , pp. 1235-1242
    • Hanyu, H.1    Asano, T.2    Iwamoto, T.3
  • 32
    • 0030797810 scopus 로고    scopus 로고
    • Medial temporal structures relate to memory impairment in Alzheimer's disease: An MRI volumetric study
    • Mori E, Yoneda Y, Yamashita H, et al. Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study. J Neurol Neurosurg Psychiatry 1997;63:214-221
    • (1997) J Neurol Neurosurg Psychiatry , vol.63 , pp. 214-221
    • Mori, E.1    Yoneda, Y.2    Yamashita, H.3
  • 33
    • 27944508285 scopus 로고    scopus 로고
    • Grouping for behavioural and psychological symptoms in dementia: Clinical and biological aspects: consensus paper of the European Alzheimer's Disease Consortium (EADC)
    • in press
    • Robert PhH, Verhey FRJ, Byrne EJ, et al. Grouping for behavioural and psychological symptoms in dementia: clinical and biological aspects: consensus paper of the European Alzheimer's Disease Consortium (EADC). Eur Psychiatry 2005 (in press)
    • (2005) Eur Psychiatry
    • Robert, Ph.H.1    Verhey, F.R.J.2    Byrne, E.J.3
  • 34
    • 0032802511 scopus 로고    scopus 로고
    • Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer's disease
    • Hanyu H, Asano T, Sakurai H, et al. Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer's disease. J Neurol Sci 1999;167:37-44
    • (1999) J Neurol Sci , vol.167 , pp. 37-44
    • Hanyu, H.1    Asano, T.2    Sakurai, H.3
  • 35
    • 0030059064 scopus 로고    scopus 로고
    • Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging
    • MacKay S, Meyerhoff DJ, Constans JM, et al. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch Neurol 1996;53:167-74
    • (1996) Arch Neurol , vol.53 , pp. 167-174
    • MacKay, S.1    Meyerhoff, D.J.2    Constans, J.M.3
  • 36
    • 0037016165 scopus 로고    scopus 로고
    • Diffusion tensor in posterior cingulate gyrus: Correlation with cognitive decline in Alzheimer's disease
    • Yoshiura T, Mihara F, Ogomori K, et al. Diffusion tensor in posterior cingulate gyrus: correlation with cognitive decline in Alzheimer's disease. Neuroreport 2002;13:2299-2302
    • (2002) Neuroreport , vol.13 , pp. 2299-2302
    • Yoshiura, T.1    Mihara, F.2    Ogomori, K.3
  • 37
    • 3042662696 scopus 로고    scopus 로고
    • Heterogeneous age-related breakdown of white matter structural integrity: Implications for cortical "disconnection" in aging and Alzheimer's disease
    • Bartzokis G, Sultzer D, Lu PH, et al. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging 2004;25:843-851
    • (2004) Neurobiol Aging , vol.25 , pp. 843-851
    • Bartzokis, G.1    Sultzer, D.2    Lu, P.H.3
  • 39
    • 0035674523 scopus 로고    scopus 로고
    • Magnetic resonance imaging findings predicting subsequent disease course in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis
    • Filippi M. Magnetic resonance imaging findings predicting subsequent disease course in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Neurol Sci 2001;22:S49-S51
    • (2001) Neurol Sci , vol.22
    • Filippi, M.1
  • 40
    • 0037122957 scopus 로고    scopus 로고
    • A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
    • Brex PA, Ciccarelli O, O'Riordan JI, et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002;346:158-164
    • (2002) N Engl J Med , vol.346 , pp. 158-164
    • Brex, P.A.1    Ciccarelli, O.2    O'Riordan, J.I.3
  • 41
    • 0034955141 scopus 로고    scopus 로고
    • Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
    • McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-127
    • (2001) Ann Neurol , vol.50 , pp. 121-127
    • McDonald, W.I.1    Compston, A.2    Edan, G.3
  • 42
    • 0344889207 scopus 로고    scopus 로고
    • Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
    • Jack CR Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397-1403
    • (1999) Neurology , vol.52 , pp. 1397-1403
    • Jack Jr., C.R.1    Petersen, R.C.2    Xu, Y.C.3
  • 43
    • 0036846604 scopus 로고    scopus 로고
    • Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment
    • Riemenschneider M, Lautenschlager N, Wagenpfeil S, et al. Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch Neurol 2002;59:1729-1734
    • (2002) Arch Neurol , vol.59 , pp. 1729-1734
    • Riemenschneider, M.1    Lautenschlager, N.2    Wagenpfeil, S.3
  • 44
    • 0037461347 scopus 로고    scopus 로고
    • Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?
    • Chetelat G, Desgranges B, De La Sayette V, et al. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 2003;60:1374-1377
    • (2003) Neurology , vol.60 , pp. 1374-1377
    • Chetelat, G.1    Desgranges, B.2    De La Sayette, V.3
  • 45
    • 0036184524 scopus 로고    scopus 로고
    • Combined analysis of CSF tau levels and [(123)I]iodoamphetamine SPECT in mild cognitive impairment: Implications for a novel predictor of Alzheimer's disease
    • Okamura N, Arai H, Maruyama M, et al. Combined analysis of CSF tau levels and [(123)I]iodoamphetamine SPECT in mild cognitive impairment: implications for a novel predictor of Alzheimer's disease. Am J Psychiatry 2002;159:474-476
    • (2002) Am J Psychiatry , vol.159 , pp. 474-476
    • Okamura, N.1    Arai, H.2    Maruyama, M.3
  • 46
    • 0036828769 scopus 로고    scopus 로고
    • Alzheimer's disease: Treatments in discovery and development
    • Citron M. Alzheimer's disease: treatments in discovery and development. Nat Neurosci 2002;5:1055-1057
    • (2002) Nat Neurosci , vol.5 , pp. 1055-1057
    • Citron, M.1
  • 47
    • 3442877049 scopus 로고    scopus 로고
    • Cortical reorganisation in patients with MS: Using functional MRI techniques to study patients with MS
    • Filippi M, Rocca MA. Cortical reorganisation in patients with MS: using functional MRI techniques to study patients with MS. J Neurol Neurosurg Psychiatry 2004;75:1087-1089
    • (2004) J Neurol Neurosurg Psychiatry , vol.75 , pp. 1087-1089
    • Filippi, M.1    Rocca, M.A.2
  • 48
    • 0032819640 scopus 로고    scopus 로고
    • Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: Patterns of functional MRI activation
    • Saykin AJ, Flashman LA, Frutiger SA, et al. Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: patterns of functional MRI activation. J Int Neuropsychol Soc 1999;5:377-392
    • (1999) J Int Neuropsychol Soc , vol.5 , pp. 377-392
    • Saykin, A.J.1    Flashman, L.A.2    Frutiger, S.A.3
  • 49
    • 0036432214 scopus 로고    scopus 로고
    • Functional imaging of visuospatial processing in Alzheimer's disease
    • Prvulovic D, Hubl D, Sack AT, et al. Functional imaging of visuospatial processing in Alzheimer's disease. Neuroimage 2002;17:1403-1414
    • (2002) Neuroimage , vol.17 , pp. 1403-1414
    • Prvulovic, D.1    Hubl, D.2    Sack, A.T.3
  • 50
    • 0344198488 scopus 로고    scopus 로고
    • Functional deactivations: Change with age and dementia of the Alzheimer type
    • Lustig C, Snyder AZ, Bhakta M, et al. Functional deactivations: change with age and dementia of the Alzheimer type. Proc Natl Acad Sci USA 2003;100:1454-1459
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 1454-1459
    • Lustig, C.1    Snyder, A.Z.2    Bhakta, M.3
  • 51
    • 3042714810 scopus 로고    scopus 로고
    • Medial temporal lobe function and structure in mild cognitive impairment
    • Dickerson BC, Salat DH, Bates JF, et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol 2004;56:27-35
    • (2004) Ann Neurol , vol.56 , pp. 27-35
    • Dickerson, B.C.1    Salat, D.H.2    Bates, J.F.3
  • 52
    • 0034840134 scopus 로고    scopus 로고
    • Memory rehabilitation in Alzheimer's disease: A review of progress
    • De Vreese LP, Neri M, Fioravanti M, et al. Memory rehabilitation in Alzheimer's disease: a review of progress. Int J Geriatr Psychiatry 2001;16:794-809
    • (2001) Int J Geriatr Psychiatry , vol.16 , pp. 794-809
    • De Vreese, L.P.1    Neri, M.2    Fioravanti, M.3
  • 53
    • 0031037995 scopus 로고    scopus 로고
    • Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials
    • Barkhof F, Filippi M, Miller DH, et al. Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials. J Neurol 1997;244:76-84
    • (1997) J Neurol , vol.244 , pp. 76-84
    • Barkhof, F.1    Filippi, M.2    Miller, D.H.3
  • 54
    • 0037161249 scopus 로고    scopus 로고
    • MRI techniques to monitor MS evolution: The present and the future
    • Filippi M, Grossman RI. MRI techniques to monitor MS evolution: the present and the future. Neurology 2002;58:1147-1153
    • (2002) Neurology , vol.58 , pp. 1147-1153
    • Filippi, M.1    Grossman, R.I.2
  • 55
    • 0033604631 scopus 로고    scopus 로고
    • Treatment of Alzheimer's disease
    • Mayeux R, Sano M. Treatment of Alzheimer's disease. N Engl J Med 1999;341:1670-1679
    • (1999) N Engl J Med , vol.341 , pp. 1670-1679
    • Mayeux, R.1    Sano, M.2
  • 56
    • 0034972863 scopus 로고    scopus 로고
    • Incorporating biomarkers into clinical drug trials in Alzheimer's disease
    • Growdon JH. Incorporating biomarkers into clinical drug trials in Alzheimer's disease. J Alzheimers Dis 2001;3:287-292
    • (2001) J Alzheimers Dis , vol.3 , pp. 287-292
    • Growdon, J.H.1
  • 57
    • 4644283049 scopus 로고    scopus 로고
    • PET imaging of amyloid in Alzheimer's disease
    • Nordberg A. PET imaging of amyloid in Alzheimer's disease. Lancet Neurol 2004;3:519-527
    • (2004) Lancet Neurol , vol.3 , pp. 519-527
    • Nordberg, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.